~~<i id='4FB8C92521'><strike id='4FB8C92521'><tt id='4FB8C92521'><pre id='4FB8C92521'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

Wikipedia

author：entertainment 2025-09-30 14:59:30 - browse：156

A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

See below for an archived chat with Helen Branswell about these issues and more.

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Congress gives doctors Medicare pay bump

focus

Wikipedia

leisure time

hotspot

leisure time

AllenInstituteCEORuiCostaCourtesyAllenInstituteMappingthebillionsofcellsthatmakeupthebrainisataskmam

WSS

Allen Institute goes after foundational questions, CEO Costa says

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

An inside look at PIPEs, biotech's buzzy new financing tool

At JPM 2024, hospital systems pitch financial strength to investors

Merck to acquire Harpoon Therapeutics for $680 million

Change Healthcare cyberattack outage could last weeks

explore

Wikipedia

focus

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

At least 13 dead in Texas as scorching temps continue

STAT Virtual Event: JPM Recap, Live!

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ALS groups 'won't be played again' by the FDA, drug sponsors

23andMe had bad news about my health. I wish a person had delivered it

Biotech companies concerned about China biosecurity crackdown

Heart attack and stroke risk calculators need revising

RaDonda Vaught to speak at CommonSpirit event on patient safety

Wikipedia

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Study suggests new cause of Down syndrome: cells linked to aging

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

In search for therapies for solid tumors, companies turn to claudin

How to fix the rural physician shortage in the U.S.

Merck to acquire Harpoon Therapeutics for $680 million

leisure time

hotspot

hotspot

leisure time